Glorymar Ibáñez

510 citations
10 papers · 304 indexed · h-index 8
Topics
Epigenetics and DNA Methylation (5 papers)Cancer-related gene regulation (5 papers)RNA modifications and cancer (3 papers)

In The Last Decade

Glorymar Ibáñez

10 papers receiving 294 citations

Peers

Glorymar Ibáñez
Comparison fields: 5 of 49
  • Molecular Biology 281
  • Organic Chemistry 20
  • Oncology 15
  • Cancer Research 14
  • Computational Theory and Mathematics 11
Replace Yann‐Vaï Le Bihan with:
Yann‐Vaï Le Bihan United Kingdom
Avinash B. Patel United States
Jacob I. Stuckey United States
Martin Karam Lebanon
Suzanna Bailey United States
Ai Ching Wong United Kingdom
Daniel W. Heindel United States
Anita Kotar Slovenia
Tian Lu China
Kenneth H. Huang Canada
Glorymar Ibáñez relative to Yann‐Vaï Le Bihan United Kingdom Yann‐Vaï Le Bihan's profile →
Citations per field
00.5×2.7×
Yann‐Vaï Le Bihan · 1×
Citations per year

Countries citing papers authored by Glorymar Ibáñez

Since Specialization
Citations

This map shows the geographic impact of Glorymar Ibáñez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glorymar Ibáñez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glorymar Ibáñez more than expected).

Fields of papers citing papers by Glorymar Ibáñez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glorymar Ibáñez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glorymar Ibáñez. The network helps show where Glorymar Ibáñez may publish in the future.

Co-authorship network of co-authors of Glorymar Ibáñez

This figure shows the co-authorship network connecting the top 25 collaborators of Glorymar Ibáñez. A scholar is included among the top collaborators of Glorymar Ibáñez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glorymar Ibáñez. Glorymar Ibáñez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 8
2 7
3 47
4 7
5 2
6 18
7 114
8 40
9 60
10 1

About Glorymar Ibáñez

Glorymar Ibáñez is a scholar working on Biophysics, Molecular Biology and Cancer Research, having authored 10 papers that have together received 304 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Molecular Biology (281 citations), Cancer Research (14 citations) and Virology (4 citations). Glorymar Ibáñez has collaborated with scholars based in United States, Venezuela and South Korea. Frequent co-authors include Minkui Luo, Gil Blum, Yaritzy M. Astudillo, Hakim Djaballah, Constantin Radu, David Shum, M.F. Amaya, Alena Siarheyeva, Peter J. Brown and Weihong Zheng. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026